                         SEQUENCE LISTING

<110>  The Research Foundation for The State University of New 
       York
 
<120>  COMPOSITIONS AND METHODS FOR IMPROVING TUMOR PENETRATION OF TUMOR
        SPECIFIC ANTIBODIES

<130>  011520.01542

<150>  US 62/898,445
<151>  2019-09-10

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  1HE

<400>  1

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Ala Gly Asp 
1               5                   10                  15      


Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Arg Thr Phe Ser Ser Val 
            20                  25                  30          


Ala Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Lys Phe Val 
        35                  40                  45              


Ala Asn Ile Ser Trp Asn Gly Asp Ser Thr Tyr Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Lys Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Asp Val Arg Trp Thr Gly Asp Gly His Arg Ala Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Gln Val Thr Val Ser Ser Leu Glu His His His His 
        115                 120                 125             


His His 
    130 


<210>  2
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  1HE without restriction site amino acids and hexahistidine tag

<400>  2

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Ala Gly Asp 
1               5                   10                  15      


Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Arg Thr Phe Ser Ser Val 
            20                  25                  30          


Ala Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Lys Phe Val 
        35                  40                  45              


Ala Asn Ile Ser Trp Asn Gly Asp Ser Thr Tyr Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Lys Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Asp Val Arg Trp Thr Gly Asp Gly His Arg Ala Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Gln Val Thr Val Ser Ser 
        115                 120         


<210>  3
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  1HE genetic sequence

<400>  3
catatggaag ttcagctggt tgaaagcggt ggtggtctgg ttcaggcagg cgatagtctg       60

accctgagct gtgcagcaag cggtcgtacc tttagcagcg ttgcaatggg ttggtttcgt      120

caggcaccgg gtaaagaacg taaatttgtt gcaaatatta gctggaatgg cgacagcacc      180

tattataccg atagcgttaa aggtcgtttt accattagcc gtgataatgc caaaaatacc      240

gtttacctgc agatgagcag cctgaaaccg gaagataccg cagtgtatta ttgtgcagca      300

gatgttcgtt ggaccggtga tggtcatcgt gcagattatt ggggtcaggg cacccaggtt      360

accgttagca gcctcgag                                                    378


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  1HE CDR2 center sequence

<400>  4

Asn Gly Asp Ser Thr 
1               5   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR3 sequence

<400>  5

Thr Gly Asp Gly His Arg Ala Asp Tyr 
1               5                   


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR1

<400>  6

Gly Arg Thr Phe Ser Ser Val Ala 
1               5               


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR2

<400>  7

Ile Ser Trp Asn Gly Asp Ser Thr Tyr Tyr Thr 
1               5                   10      


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR3

<400>  8

Ala Ala Asp Val Arg Trp Thr Gly Asp Gly His Arg Ala Asp Tyr 
1               5                   10                  15  


